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found to have adequate knowledge and practice. Significant associations were 
noted for knowledge-practice groups with parent’s age, education level, and family 
income (p< 0.05). ConClusions: Understanding parents’ knowledge and practice 
is an important factor in order to improve immunization uptake and timeliness. 
Educational interventions targeting parents with inadequate knowledge and prac-
tice about childhood immunization are needed.
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objeCtives: Women of childbearing age are more likely to suffer from depression 
and anxiety disorders. Maternal depression has been associated with adverse birth 
outcomes such as preterm delivery, low birth weight/small for gestational age, etc. 
The objectives of this study are (i) to determine the prevalence of antidepressant 
utilization in pregnant women (ii) to identify factors associated with the use of 
antidepressants during pregnancy. Methods: We used data of 1428 United States 
women (age ≥ 20 years) who participated in the National Health and Nutrition 
Examination Survey (NHANES) from 2001 to 2012 (this is a cross-sectional health 
examination survey of the US population) and who were known to be pregnant at 
the time of the interview. Antidepressant utilization was assessed as reported by the 
study participants. Logistic regression models were used to identify factors associ-
ated with receiving an antidepressant during pregnancy. Results: The prevalence 
of antidepressant use increased from 3.1 % to 9.7% in from 2001 to 2012 (p< 0.01). 
Among those women who reported using antidepressants 15.45% had a diagnosis of 
clinical depression. Selective Serotonin Reuptake Inhibitors (SSRIs) were found to be 
the most commonly prescribed class of antidepressants (78.9%). Race was found to 
be a strong predictor of antidepressant use, Non-Hispanic White women were found 
to be more likely to be on antidepressants as compared to other races (OR = 3.1; 
95%CI 1.95 – 4.56). The other factors found to be significantly associated with anti-
depressant use were age, diagnosis of depression, and education. ConClusions: 
Utilization of antidepressants during pregnancy has increased in the past decade, 
specially the use of SSRIs. The prescription of antidepressants varies significantly 
by age, race, and education. Although an increase in antidepressant use potentially 
signifies treatment of maternal depression, it stresses the need for clinical guide-
lines to treat maternal depression.
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objeCtives: Birthweight is a strong predictor of an individual baby’s survival as 
well as overall infant mortality and low birthweight is associated with adverse 
health outcomes. This study utilized a linear regression model to predict a child’s 
birthweight from the mother’s race, education level, smoking status, and gestation 
age. Methods: A publically available dataset of births in Philadelphia, PA from 
1990 had 1,115 observations on five variables: mother’s race, years of education, 
and smoking status during pregnancy; and gestational age (weeks) and birthweight 
(gms). The dataset was randomly divided into 2 subsets for model development and 
validation. The model was developed against the development dataset, verified 
against the validation dataset, and refitted to the entire sample to generate the final 
results. Results: The final fitted model was: Y = b0 + b1X1 + b2X3 + b3X4 + b4X1X3 
+ b5 X42 (R2= 0.5337, Ra2= 0.5316, p< .0001); where X1 indicates the mother’s race was 
black, X3 indicates the mother smoked during pregnancy, and X4 represents gesta-
tion age (centered). Mother’s education was dropped from the model due to lack of 
significance. Negative effects were observed for race (b1= -227.22, 95% CI: [-287.01, 
-167.43], p< .0001) and smoking (b2= -316.59, 95% CI: [-414.16, -219.02], p< .0001), while 
a positive effect was observed for the interaction of race and smoking (b4= 210.31, 
95% CI: [86.80, 333.82], p= .0009). With respect to gestation age, the positive linear 
effect (b3= 144.90, 95% CI: [129.63, 160.16], p< .0001) was slightly offset by a small 
negative quadratic effect (b5= -1.47, 95% CI: [-2.84, -0.10], p= .0351). ConClusions: 
The results indicate that premature birth, mother’s race, and smoking during preg-
nancy are risk factors for lower birthweight, but the combined effect of a black 
mother who smoked during pregnancy is sub-additive. Mother’s education is not 
an independent risk factor, after controlling for these other factors.
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objeCtives: There is an increasing trend of stillbirth in Mongolia for the last few 
years and Ulaanbaatar city is the 2nd most polluted city in the world by WHO. 
This study sought to determine the association of outdoor air pollution and risk 
of stillbirth. Methods: This was a case-control study. The case group consisted of 
909 stillbirths and the controls included 159 764 live births from singletons born 
in 2008-2013 in Ulaanbaatar. Air quality data between January 2007 and December 
2013 was obtained. Association between air pollution and stillbirth was determined 
using Logit regression. Odds ratios were estimated per 10-ppb change for nitrogen 
dioxide (NO2), sulfur dioxide (SO2) and for particulate matter with aerodynamic 
diameter ≤ 10 μ m (PM10), and 100-ppb change for carbon monoxide (CO) during 
different gestational periods. Results: Average duration of gestation for stillbirths 
were 24.7 weeks whereas for live births average duration was 38.5 weeks (p< 0.0001). 
28.2% of stillbirths occurred in spring. Stillbirth risk increased in association with 
10-ppb change for SO2 in all trimesters (OR= 1.01; CI 95% 0.99-1.03). Stillbirth risk also 
increased in association with 10-ppb change for NO2 in first-trimester (OR= 1.01; CI 
95% 0.96-1.07). 100-ppb change for CO during all trimesters of gestation increased 
risks of stillbirth (OR= 1.01; CI 95% 0.98-1.04). There was an increased risk of still-
births in association with 10-ppb change for PM10in first-trimester (OR= 1.02; CI 
95% 0.99-1.04). ConClusions: Exposure to outdoor air substances may increase 
the risk of stillbirth, and that the most susceptible time periods for exposure are 
during the first trimester of gestation.
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objeCtives: Infection rates associated with intrathecal baclofen pump (ITBP) pro-
cedures are 4.5-9%. Practice guidelines recommend appropriate administration of 
perioperative antimicrobial prophylaxis (cefazolin or vancomycin monotherapy) 
to reduce surgical infection, which is expected to decrease morbidity and mor-
tality, and control duration/cost of care. This study explored the prevalence and 
specific antibiotic prophylaxis (AP) used in pediatric patients undergoing ITBP 
placement and factors associated with compliance of AP use. Methods: Using 
Pediatrics Health Information System (PHIS), the study cohort comprised patients 
who had ITBP surgery (ICD-9 CM procedure code 86.06) within 3 days of admission, 
between 7/1/2004-12/31/2013, with minimum follow up 90 days. Exclusion criteria 
were prior infection, antibiotic use within 30 days of admission, and/or missing 
financial data. Chi-squared test and multivariate logistic regression were used to 
determine factors associated with compliance to AP administration in ITBP surger-
ies. Analyses used SAS®9.3 software. Results: 1561 patients met inclusion criteria. 
89.3% received AP; among those, 34.1% received at least dual coverage. The most 
frequently used antibiotics in surgery were cefazolin (N= 882, 62.3%), vancomycin 
(345, 24.4%) as per guideline recommendations. Documented AP administration 
compliance rates were 74.3%, 64.8%, 70.7%, and 58.4% in West, South, Midwest, and 
Northeast regions, respectively. Compared to surgeries in the Northeast, procedures 
in the West (Odds Ratio, 2.1, 95% confidence interval 1.4-3.0, p< 0.001) and Midwest 
(1.7, 1.2-2.4, p= 0.003) were more likely to have AP compliance. Black (0.71, 0.52-0.96, 
p= 0.025) and Hispanic (0.62, 0.45-0.86, p= 0.005) patients were less likely to have AP 
compliance in surgeries than White patients. There were no significant differences 
of compliance by age, sex, insurance, and diagnosis. ConClusions: Close to 70% 
of ITBP surgeries show compliance with perioperative AP guidelines. Geographic, 
race, and practice variation in ITBP antibiotic prophylaxis were found in this study. 
Future research is warranted to examine these variations and resultant impact on 
surgical infection and outcomes.
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objeCtives: To examine the fracture-related cost burden and healthcare 
resource utilization among post-menopausal women in the U.S. Medicare popu-
lation. Methods: Post-menopausal women were identified using International 
Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnosis 
codes from the U.S. Medicare claims dataset from 01JAN2008 through 31DEC2012. 
The first fracture diagnosis date was designated as the index date. One year of 
continuous health plan enrollment was required for all patients pre- and post-
index date. A comparison group was created, identifying patients without fractures 
of the same age, region, gender and index year and were matched to case patients 
based on baseline Charlson Comorbidity Index scores. A randomly chosen index 
date for the comparison group reduced selection bias. Healthcare costs and utiliza-
tions were compared using 1:1 propensity score matching (PSM). Results: Before 
matching (n= 182,124), patients with fractures were more likely to be white (92.6% 
vs. 85.8%), reside in the Northeast U.S. region (19.4% vs. 16.4%), and have diagno-
sis of depression (18.0% vs. 13.0%) and chronic obstructive pulmonary disease 
(26.3% vs. 23.3%). After 1:1 PSM, 65,549 patients were included in each cohort and 
baseline characteristics were well-balanced. Significantly more post-menopausal 
women with fractures had inpatient admission (42.3% vs. 8.6%, p< 0.0001), outpa-
tient (80.3% vs. 48.7%, p< 0.0001), home health agency (31.2% vs. 6.9%, p< 0.0001) 
skilled nursing facility (SNF) (25.7% vs. 2.72%, p< 0.0001) and hospice admission 
(1.4% vs. 1.0%, p< 0.0001) claims. Higher healthcare resource utilization trans-
lated to higher costs for post-menopausal fracture patients, including inpatient 
($7,869 vs. $1,203, p< 0.0001), outpatient ($1,928 vs. $622, p< 0.0001), SNF ($5,980 
vs. $437, p< 0.0001), hospice ($338 vs. $244, p< 0.0001), pharmacy ($1,052 vs. $829, 
p< 0.0001) and total costs ($23,097 vs. $5,247, p< 0.0001), than for those in the com-
parison cohort. ConClusions: Post-menopausal women with fractures in the 
U.S. Medicare population had higher healthcare resource utilization and expen-
ditures than those without fractures.
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objeCtives: To understand the cost range for pediatric vaccine administration 
across different countries and to describe the costing methodologies employed 
